Effects of iloprost on adhesion molecules and F1 + 2 in peripheral ischemia

European Journal of Clinical Investigation

Volumn 32, Issue 12, 2002, Pages 882-888

  Mazzone, Antonino ^a,b   Faggioli, P ^a   Cusa, C ^a   Stefanin, C ^a   Rondena, M ^a   Morelli, B ^a  

^a Ospedale Civile di Legnano   (Italy)

^b Legnano Hospital   (Italy)

Author keywords

Adhesion molecules; Atherosclerosis; F1 + 2; Iloprost; Systemic sclerosis

Indexed keywords

CELL ADHESION MOLECULE; ENDOPROST; ILOPROST; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUSHING; HUMAN; HUMAN TISSUE; MALE; MICROVASCULATURE; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMIC SCLEROSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ILOPROST; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PROTHROMBIN; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC;

EID: 0036460739     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01095.x     Document Type: Article

References (37)

1. Black CM, Stephens CO. Scleroderma-systemic sclerosis. In: Maddison PJ, Isemberg DA, Woo P, Glass DN, editors. Oxford Textbook of Rheumatology. Oxford, UK. Oxford University Press;1993.pp.771-89.
2. Xu SW, Denton CP, Dashwood MR, Abraham DJ, Black CM. Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts. J Cardiovasc Pharmacol 1998;31-1:S 545-7.
3. Ross R. Atherosclerosis: An inflammatory disease. NEMJ 1999;340:115-26.
4. Denton CP. Vascular cells and their products in the pathogenesis of systemic sclerosis. Sem Clin Immunol 2000;20:7-13.
5. Grant S, Goa K. Iloprost (Review). Drugs 1992;43:889-924.
6. Mazzone A, Mazzucchelli I, Fossati G, Gritti D, Girola S et al. Iloprost effects on phagocytes in patients suffering from ischaemic disease: In vivo evidence for down-regulation of αMβ2 integrin. Eur J Clin Invest 1996;26:860-6.
7. Mazzone A, De Servi S, Mazzucchelli I, Fossati G, Gritti D et al. Increased expression of CD11/CD18 on Phagocytes in ischemic disease: A bridge between inflammation and coagulation. Eur J Clin Invest 1997;27:648-52.
8. Blann A. Circulating ICAM-1 and VCAM-1 in peripheral arthery disease and hypercolesterolemia: Relationship to location of the atherosclerotic disease, smoking and in predictor of adverse events. Thromb Haemost 1998;79:1080-5.
9. Gruschwitz JD, Hornstein DP, Von den Driesch P. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995;38 (2):184-9.
10. Veale DJ, Kirk GMC, Laren M, Belch JJ. Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis. Br J Rheumatol 1998;37:1227-8.
11. Denton CP, Bickerstaff MC, Shiwen X, Carulli MT, Haskard DO et al. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol 1995;34 (11):1048-54.
12. Herrick AL, Illingworth K, Blann A, hay CR, Hollis S, Jayson MT. Von Willebrand factor, thrombomodulin, thromboxane, β-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 1996;55 (2):122-7.
13. Scheja A, Akesson A, Geborek P, Wildt M, Wollheim CB et al. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Res 2001;3:178-82.
14. Aronson DL, Stevan L, Ball AP, Franza B, Rjr Finlayson JS. Generation of the combined prothrombin activation peptide (F1 + 2) during the clotting of blood and plasma. J Clin Invest 1977;60:1410-8.
15. Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C et al. The coagulation/fibrinolysis balance in systemic sclerosis: Evidence for a haematologic stress syndrome. Br J Rheumatol 1997;36:1045-50.
16. Crutchley DJ, Hirsh MJ. The stable prostacyclin analogue Iloprost and prostaglandin E-1 inhibit monocyte procoagulant activity in vitro. Blood 1991;15:78 (2): 382-6.
17. Le Roy EC, Smith EA, Kahaleh B, Trojanowska M, Silver RM. A strategy for determining the pathogenesis of systemic sclerosis. Arthritis Rheum 1989;32:819-25.
18. Stato S. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis. Association with extend of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 2000;27:149-54.
19. Bunker CB, Terenghi G, Springall DR, Polak JM, Dowd PM. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon. Lancet 1990;336:1530-3.
20. Stratton R, Shi-Wen X, Martini G, Holmes A, Leask A, Haberberger T. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001;108 (2):241-50.
21. Toothill VJ, Van Mourik JA, Niewenhuis HK, Metzelaar MJ, Pearson JD. Characterization of the enhanced adhesion of neutrophil leukocyte to thrombin-stimulated endothelial cells. J Immunol 1990;145 (1):283-91.
22. Mazzone A, De Servi S, Mazzucchelli I, Bossi I, Ottini E et al. Increased concentration of inflammatory mediators in unstable angina: Correlation with serum troponin T. Heart 2001;85:571-75.
23. Von Asmuth EJU, Van Der Linden CJ, Leeuwenberg JF, Buurman WA. Involvement of the CD11b/CD18 integrin, but not of the endothelial cell adhesion ELAM-1 and ICAM-1 in tumor necrosis factor-α-induced neutrophil toxicity. J Immunol 1991;67 (4):241-50.
24. Beekhuizen H, Blokland I, Van Furth R. Cross-linking of CD14 molecules on monocytes results in a CD11/CD18 and ICAM-1 dependent adherence to cytokine-stimulated human endothelial cells. J Immunol 1993;150 (3):950-9.
25. Ihn H, Sato S, Fujimoto M, Takehara K, Tamaki K. Serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis. Br J Rheumatol 1998;37 (11):1188-92.
26. Denton CP, Bickerstaff MC, Shi-Wen X. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol 1995;34:1048-54.
27. Clausen P, Jacobsen P, Rossin K, Jensen JS, Parving HH, Feldt-Rasmussen B Plasma concentration of VICAM-1 and ICAM-1 are elevated in patients with type 1 diabetes mellitus with mycroalbuminuria and overt nephropathy. Diabet Med 2000;17:644-9.
28. Mazzone A, Cusa C, Mazzucchelli I, Vezzoli M. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med 2001;39:822-6.
29. John S, Jacobi J, Delles C. Plasma soluble adhesion molecules and endothelium dependent vasodilatation in early human atherosclerosis. Clin Sci 2000;98:521.
30. Brevetti G, Martone VD, Cristofaro T, Corrado S, Silvestro A et al. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 2001; 85:63-6.
31. Ikata J. Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis 2000;11:445-9.
32. Peter K, Weirich U, Nordt TK. Soluble vascular adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis. Thromb Haemost 1999;82:38-43.
33. Mazzone A, Cusa C, Bucci L, Vezzoli M, Ghio S, Buggia L. The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischemia. Eur J Clin Invest 1999;29 (1):1-5.
34. Toothill VJ, Van Mourik JA, Niewenhuis HK, Metzelaar MJ, Pearson JD. Characterisation of the enhanced adhesion of neutrophil leukocyte to thrombin-stimulated endothelial cells. J Immunol 1990;145:283-91.
35. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin (ogen) is internalized and degraded by activated human monocytoid cells via Mac-;1 (CD11b:/CD18): A non plasmin fibrinolytic pathway. Blood 1993;82:2414-22.
36. Altieri DC, Morrissey JH, Edgington TS. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: An alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci USA 1988;85 (20):7462-71.
37. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1 dependent pathway. Cell 1993;73 (7):11423-34.